Medivir has appointed Erik Björk as Chief Financial Officer effective January 3, 2018.
Björk will join Medivir from AstraZeneca where he has been the CFO for Sweden Operations. He has extensive experience as a global financial leader having previously held various financial roles including division CFO, financial planning and controller positions, at Proctor & Gamble in Switzerland, the UK and Sweden. Erik has an MSc in Business and Economics and a Master of Laws both from Lund University.
"I am delighted to welcome Erik to Medivir. He brings a combination of industry experience in strong operating companies and specialized investment and financial reporting skills and we look forward to his contributions in supporting Medivir's growth," said Christine Lind, CEO at Medivir.
Björk will be a member of the Medivir Executive Team and report to Christine Lind, CEO. His responsibilities will include leading the operational activities of the Finance & Administration function and Investor Relations.
"Medivir's mission to bring transformative drugs to patients gives it a clear purpose, strong values and a positive culture. I am excited to become part of a company that has already achieved so much, that has a strong development pipeline, and to assist in realizing the company's potential," Björk said.